LGH 37424 Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Study of Hematopoietic Cell Transplantation and Marrow Toxic Injuries

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies.

A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

This study investigates hematopoietic cell transplantation and other cellular therapies, as well as marrow toxic injuries. The purpose is to collect observational data to better understand these conditions.

The study will gather data from participants who undergo routine care, without altering their treatments. This observational study aims to create a comprehensive database that can inform future research in these areas.

  • Who can participate: Eligibility criteria are yet to be determined.
  • Study details: Participants will provide data as part of their routine care. No changes to treatment are required for participation.
Updated on 22 Apr 2026. Study ID: 24-1440
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator